Valeant CEO says no need to adjust offer for Allergan
June 17 (Reuters) - Valeant Pharmaceuticals Inc Chief Executive Officer Mike Pearson said on Tuesday that he sees no need to adjust the company's offer for Allergan Inc .
Valeant's bid includes both stock and cash, but its shares have fallen for 10 straight sessions. (Reporting by Rod Nickel in Winnipeg, Manitoba)
© Thomson Reuters 2017 All rights reserved.